Janux Therapeutics, Inc. · NASDAQ:JANX
Dobmeier Eric received 5,500 Janux Therapeutics, Inc. shares as an award (Form 4)
Traded Jun 11, 2026 · Filed Jun 12, 2026
On Jun 11, 2026, Dobmeier Eric (Director) received 5,500 Janux Therapeutics, Inc. shares as an award, leaving 15,481 shares. Filed Jun 12, 2026 (Form 4).
- Awarded
- 5,500 shares
- Holding after
- 15,481 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 11, 2026 | Common Stock | Award | 5,500 | 15,481 | Direct |
Source
Related
- Janux Therapeutics, Inc.
- Dobmeier Eric
- Janux Therapeutics, Inc. shareholders
- Schedule 13G/A · Point72 Asset Management, L.P. · Aug 14, 2026
- Schedule 13G/A · Janus Henderson Group PLC · Aug 13, 2026
- Form 4 · Campbell David Alan · Jul 31, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 28, 2026
- Form 4 · Campbell David Alan · Jul 10, 2026